President Donald Trump said Thursday of which the federal government will follow the example set by states along with cities along with begin suing drug companies along with distributors for their role from the opioid epidemic.
“I keep saying, ‘If the states are doing the idea, why isn’t the federal government doing the idea?'” Trump said during a surprise appearance at the White House’s opioid summit.
“So, of which will happen,” Trump said. “of which will happen.”
The president said he has already spoken to Attorney General Jeff Sessions about taking such federal action against the makers of prescription painkillers.
About 62,000 Americans died by drug overdoses in 2016, with most of those cases related to either prescription opioids, heroin along with synthetic opioids such as fentanyl.
The negative economic effect of the opioid crisis recently was estimated to be more than $1 trillion by 2001 through last year, primarily by a loss in earnings along with productivity by victims of fatal ODs.
Trump also said Thursday of which the U.S. needs to get tough with drug dealers.
He said some other countries which impose the death penalty for illegal drug selling have fewer problems with drug abuse than the U.S.
If the federal government actually does sue opioid manufacturers, the idea might be going significantly further than an action announced Tuesday.
Sessions of which day revealed of which the Justice Department might be filing a so-called statement of interest in hundreds of lawsuits of which states along with municipalities along with Native American tribes already have pending against opioid makers.
The lawsuits, which claim of which drugmakers, distributors along with dispensers misled customers about the risks of addiction by opioids, have been consolidated in an action pending in U.S. District Court in Cleveland. The company defendants from the pending lawsuits have either publicly denied the allegations in statements to the media, or have declined to comment.
although “the statement of interest does not make the government party to the lawsuit,” attorney Jesse Gessin told NBC News for a story published Thursday.
Gessin was one of several lawyers quoted by NBC who were skeptical of which the Trump administration will get aggressive with drug companies over the issue.